Rafael Dib (@dibrafa) 's Twitter Profile
Rafael Dib

@dibrafa

Opinions are my own

ID: 807048937

linkhttp://linkedin.com/in/rafael-dib/ calendar_today06-09-2012 15:25:36

8 Tweet

73 Followers

452 Following

Rossa O'Keeffe-O'Donovan (@rossaokod) 's Twitter Profile Photo

Open Philanthropy Global Health and Wellbeing Cause Prioritisation team is hiring right now, deadline 28 Jan. It's a mixture of academic background types (research fellows) and policy / private sector types (strategy fellows) trying to figure out how best to spend $300m+ a year

Open Philanthropy (@open_phil) 's Twitter Profile Photo

One of Open Philanthropy’s goals is to collaborate more often with other funders. Today, we’re excited to announce our biggest collaboration to date – the Lead Exposure Action Fund (LEAF). Lead exposure causes an estimated 1.5 million deaths each year. But until recently, total

One of Open Philanthropy’s goals is to collaborate more often with other funders. Today, we’re excited to announce our biggest collaboration to date – the Lead Exposure Action Fund (LEAF).

Lead exposure causes an estimated 1.5 million deaths each year. But until recently, total
Open Philanthropy (@open_phil) 's Twitter Profile Photo

Our Science team has backed hundreds of global health projects since 2016. From improving nutrition for malnourished children to advancing malaria vaccines, read five highlights that showcase our approach to hits-based giving: openphilanthropy.org/research/five-…

Open Philanthropy (@open_phil) 's Twitter Profile Photo

From Open New York helping to pass NYC's largest zoning reform in 50 years to The Humane League improving welfare for 350M chickens, our grantees achieved incredible progress in 2024. Read more "cool things" from our Global Health & Wellbeing portfolio here:

Alexander Berger (@albrgr) 's Twitter Profile Photo

1/ For over 100 years, we've relied on the same TB vaccine, which only partially protects children and doesn't work in adults. That could finally change with MTBVAC, a new vaccine candidate whose first Phase II b trial doses were administered last week in South Africa. 🧵

1/ For over 100 years, we've relied on the same TB vaccine, which only partially protects children and doesn't work in adults. That could finally change with MTBVAC, a new vaccine candidate whose first Phase II b trial doses were administered last week in South Africa. 🧵
Open Philanthropy (@open_phil) 's Twitter Profile Photo

We’re proud to have backed Amy Pickering (Amy Pickering) and her team in developing the TuriTap: an inexpensive, low-tech water chlorination device. Read more about Pickering’s work in our latest grantee spotlight: openphilanthropy.org/research/how-a…

We’re proud to have backed Amy Pickering (<a href="/SeqH2O/">Amy Pickering</a>) and her team in developing the TuriTap: an inexpensive, low-tech water chlorination device. Read more about Pickering’s work in our latest grantee spotlight:
openphilanthropy.org/research/how-a…